Abstract
The experience of pain is often associated with negative affect, such as anxiety and depression, and this relationship is evident in adult cancer patients, particularly those with advanced disease. Effective management of pain in cancer patients cannot be achieved without addressing co-occurring psychological factors (Portenoy 2011). The aim of this chapter is to summarize knowledge about depression and anxiety as they relate to pain in adult cancer patients. We will briefly review the etiology and prevalence of pain before summarizing the existing knowledge about the relationship of depression and anxiety to pain in adult cancer patients. We will then provide an overview of the etiology, methods of assessment, prevalence, and management of depression and anxiety as it pertains to adult cancer patients. Examples of studies conducted with cancer patients with pain and with palliative care patients will be discussed when relevant. Finally, we conclude with future directions for addressing depression and anxiety in cancer patients with pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., & Mott, L. A. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncol, 12, 612–619.
Akechi, T., Okuyama, T., Onishi, J., Morita, T., & Furukawa, T. A. (2008). Psychotherapy for depression among incurable cancer patients. Cochrane Database of Systematic Reviews, 2, CD005537.
Akechi, T., Okuyama, T., Uchida, M., Nakaguchi, T., Sugano, K., Kubota, Y., et al. (2012). Clinical indicators of depression among ambulatory cancer patients undergoing chemotherapy. Japanese Journal of Clinical Oncology, 42(12), 1175–1180.
Allard, P., Maunsell, E., Labbe, J., & Dorval, M. (2001). Educational interventions to improve cancer pain control: A systematic review. Journal of Palliative Medicine, 4(2), 191–203.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). Washington, DC: American Psychiatric Pub.
Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., et al. (2014). Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation. Journal of Clinical Oncology, 32(15), 1605–1619.
Andrew, B., Ng, C., & Jaafar, N. (2017). The use of methylphenidate in cancer patients: A review. Current Drug Targets, 19(8), 877–887.
Andrisano, C., Chiesa, A., & Serretti, A. (2013). Newer antidepressants and panic disorder: A meta-analysis. International Clinical Psychopharmacology, 28(1), 33–45.
Arathuzik, D. (1994). Effects of cognitive-behavioral strategies on pain in cancer patients. Cancer Nursing, 17, 207–214.
Bakker, A., van Balkom, A. J., & Spinhoven, P. (2002). SSRIs vs. TCAs in the treatment of panic disorder: A meta-analysis. Acta Psychiatrica Scandinavica, 106(3), 163–167. doi: 2r255 [pii].
Baldwin, D. S., Waldman, S., & Allgulander, C. (2011). Evidence-based pharmacological treatment of generalized anxiety disorder. International Journal of Neuropsychopharmacology, 14(5), 697–710.
Barsevick, A. M., Sweeney, C., Haney, E., & Chung, E. (2002). A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncology Nursing Forum, 29(1), 73–84; quiz 85-77.
Beck, A. T., & Steer, R. A. (1990). Manual for the Beck anxiety inventory. San Antonio: Psychological Corporation.
Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford Press.
Bennett, M. I., Bagnall, A.-M., & Closs, S. J. (2009). How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. PAIN®, 143(3), 192–199.
Berney, A., Stiefel, F., Mazzocato, C., & Buclin, T. (2000). Psychopharmacology in supportive care of cancer: A review for the clinician. III. Antidepressants. Support Care Cancer, 8(4), 278–286.
Bishop, S. R., & Warr, D. (2003). Coping, catastrophizing and chronic pain in breast cancer. Journal of Behavioral Medicine, 26(3), 265–281.
Blake, D. D., Weathers, F., Nagi, L. M., Kaloupek, D. G., Klauminzer, G., Charney, D. S., & Keane, T. M. (1990). A clinician's rating scale for assessing current and lifetime PTSD: The CAPS 1. Behavior Therapist, 13, 187–188.
Boettger, S., Jenewein, J., & Breitbart, W. (2015). Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. Palliative & Supportive Care, 13(4), 1079–1085.
Bottomley, A. (1998). Depression in cancer patients: A literature review. European Journal of Cancer Care, 7, 181–191.
Braun, I. M., & Pirl, W. F. (2010). Psychotropic medications in Cancer care. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, M. S. Lederberg, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology (pp. 378–385). New York: Oxford University Press.
Bredal, I. S., Smeby, N. A., Ottesen, S., Warncke, T., & Schlichting, E. (2014). Chronic pain in breast cancer survivors: Comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain. Journal of Pain and Symptom Management, 48(5), 852–862.
Breitbart, W., Rosenfeld, B., Pessin, H., Applebaum, A., Kulikowski, J., & Lichtenthal, W. G. (2015). Meaning-centered group psychotherapy: An effective intervention for improving psychological well-being in patients with advanced cancer. Journal of Clinical Oncology, 33(7), 749–754.
Brintzenhofe-Szoc, K. M., Levin, T. T., Li, Y., Kissane, D. W., & Zabora, J. R. (2009). Mixed anxiety/depression symptoms in a large cancer cohort: Prevalence by cancer type. Psychosomatics, 50(4), 383–391. https://doi.org/10.1176/appi.psy.50.4.383 50/4/383 [pii].
Brown, J. H., & Parakevas, F. (1982). Cancer and depression: Cancer presenting with depressive illness: An autoimmune disease? The British Journal of Psychiatry, 141, 227–232.
Bryant, R. A., Harvey, A. G., Dang, S. T., & Sackville, T. (1998). Assessing acute stress disorder: Psyshometric properties of a structured clinical interview. Psychological Assessment, 10, 215–220.
Buclin, T., Mazzocato, C., Berney, A., & Stiefel, F. (2001). Psychopharmacology in supportive care of cancer: A review for the clinician. IV. Other psychotropic agents. Support Care Cancer, 9(4), 213–222.
Buffart, L. M., Van Uffelen, J. G., Riphagen, I. I., Brug, J., van Mechelen, W., Brown, W. J., & Chinapaw, M. J. (2012). Physical and psychosocial benefits of yoga in cancer patients and survivors, a systematic review and meta-analysis of randomized controlled trials. BMC Cancer, 12(1), 559.
Bukberg, J., Penman, D., & Holland, J. C. (1984). Depression in hospitalized cancer patients. Psychosomatic Medicine, 46(3), 199–212.
Campeau, M.-P., Gaboriault, R., Drapeau, M., Van Nguyen, T., Roy, I., Fortin, B., et al. (2007). Impact of massage therapy on anxiety levels in patients undergoing radiation therapy: Randomized controlled trial. Journal of the Society for Integrative Oncology, 5(4).
Cankurtaran, E. S., Ozalp, E., Soygur, H., Akbiyik, D. I., Turhan, L., & Alkis, N. (2008). Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: Superiority over imipramine. Supportive Care in Cancer, 16(11), 1291–1298.
Capuron, L., Ravaud, A., & Dantzer, R. (2000). Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. Journal of Clinical Oncology, 18(10), 2143–2151.
Capuron, L., Gumnick, J. F., Musselman, D. L., Lawson, D. H., Reemsnyder, A., Nemeroff, C. B., & Miller, A. H. (2002). Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology, 26, 643–652.
Carlson, L. E., Angen, M., Cullum, J., Goodey, E., Koopmans, J., Lamont, L., et al. (2004). High levels of untreated distress and fatigue in cancer patients. British Journal of Cancer, 90(12), 2297–2304. https://doi.org/10.1038/sj.bjc.6601887 6601887 [pii].
Carr, D., Goudas, L., Lawrence, D., Pirl, W., Lau, J., DeVine, D., et al. (2002). Management of cancer symptoms: Pain, depression, and fatigue. Evidence Report/Technology Assessment No. 61. AHRQ Publication No. 02-E032. Rockville: Agency for Healthcare Research and Quality.
Cassileth, B. R., Deng, G. E., Gomez, J. E., Johnstone, P. A., Kumar, N., & Vickers, A. J. (2007). Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 132(3 Suppl), 340S–354S. https://doi.org/10.1378/chest.07-1389 132/3_suppl/340S [pii].
Chen, M.-L., Chang, H.-K., & Yeh, C.-H. (2000). Anxiety and depression in Taiwanese cancer patients with and without pain. Journal of Advanced Nursing, 32(4), 944–951.
Cheung, Y. L., Molassiotis, A., & Chang, A. M. (2003). The effect of progressive muscle relaxation training on anxiety and quality of life after stoma surgery in colorectal cancer patients. Psycho-Oncol, 12, 254–266.
Chochinov, H. M., Wilson, K. G., Enns, M., & Lander, S. (1997). “Are you depressed?” screening for depression in the terminally ill. The American Journal of Psychiatry, 154(5), 674–676.
Ciaramella, A., & Poli, P. (2001). Assessment of depression among cancer patients: The role of pain, cancer type and treatment. Psychooncology, 10(2), 156–165. https://doi.org/10.1002/pon.505 [pii].
Cleeland, C. S. (1984). The impact of pain on the patient with cancer. Cancer, 54(11 Suppl), 2635–2641.
Crane, R. (2017). Mindfulness-based cognitive therapy: Distinctive features. Routledge: Taylor & Francis.
Dahl, A. A., Haaland, C. F., Mykletun, A., Bremnes, R., Dahl, O., Klepp, O., et al. (2005). Study of anxiety disorder and depression in long-term survivors of testicular cancer. Journal of Clinical Oncology, 23, 2389–2395. https://doi.org/10.1200/JCO.2005.05.061 23/10/2389 [pii].
Dalton, J. A., Keefe, F. J., Carlson, J., & Youngblood, R. (2004). Tailoring cognitive-behavioral treatment for cancer pain. Pain Management Nursing, 5(1), 3–18. doi: S1524904203000274 [pii].
Deng, D., Fu, L., Zhao, Y. X., Wu, X., Zhang, G., Liang, C., et al. (2012). The relationship between cancer pain and quality of life in patients newly admitted to Wuhan hospice Center of China. American Journal of Hospice and Palliative Medicine®, 29(1), 53–59.
Derogatis, L. R., Morrow, G. R., Fetting, J., Penman, D., Piasetsky, S., Schmale, A. M., et al. (1983). The prevalence of psychiatric disorders among cancer patients. JAMA, 249(6), 751–757.
Devine, E. C. (2003). Meta-analysis of the effect of psychoeducational interventions on pain in adults with cancer. Oncology Nursing Forum, 30(1), 75–89. https://doi.org/10.1188/03.ONF.75-89.
Devine, E. C., & Westlake, S. K. (1995). The effects of psychoeducational care provided to adults with cancer: Meta-analysis of 116 studies. Oncology Nursing Forum, 22, 1369–1381.
DuHamel, K. N., Mosher, C. E., Winkel, G., Labay, L. E., Rini, C., Meschian, Y. M., et al. (2010). Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 28(23), 3754–3761. https://doi.org/10.1200/JCO.2009.26.8722 JCO.2009.26.8722 [pii].
Edelman, S., Bell, D. R., & Kidman, A. D. (1999). A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psycho-Oncol, 8(4), 295–305.
Eli Lilly and Company. (2017). Cymbalta Medication Guide. From https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021427s049lbl.pdf
Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., & Küffner, R. (2013). Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. Journal of Clinical Oncology, 31(6), 782–793.
Fallowfield, L., Ratcliffe, D., Jenkins, V., & Saul, J. (2001). Psychiatric morbidity and its recognition by doctors in patients with cancer. British Journal of Cancer, 84(8), 1011–1015. https://doi.org/10.1054/bjoc.2001.1724 S0007092001917240 [pii].
Feyer, P., & Jordan, K. (2010). Update and new trends in antiemetic therapy: The continuing need for novel therapies. Annals of Oncology. https://doi.org/10.1093/annonc/mdq600 mdq600 [pii].
First, M. B., Gibbons, M., & Spitzer, R. L. (1996). Users guide for the structured clinical interview for DSM-IV axis I disorders: Research version. New York: Biometrics Research.
Fischer, D. J., Villines, D., Kim, Y. O., Epstein, J. B., & Wilkie, D. J. (2010). Anxiety, depression, and pain: Differences by primary cancer. Support Care Cancer, 18(7), 801–810. https://doi.org/10.1007/s00520-009-0712-5.
Fitzgibbon, D. (2010). Mechanisms, assessment, and diagnosis of pain due to cancer. In Bonica’s management of pain (pp. 559–582). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins.
Glover, J., Dibble, S. L., Dodd, M. J., & Miaskowski, C. (1995). Mood states of oncology outpatients: Does pain make a difference? Journal of Pain and Symptom Management, 10(2), 120–128. doi: 088539249400073T [pii].
Goodwin, P. J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. The New England Journal of Medicine, 345, 1719–1726.
Greer, S., Moorey, S., Baruch, J. D., Watson, M., Robertson, B. M., Mason, A., et al. (1992). Adjuvant psychological therapy for patients with cancer: A prospective randomised trial. BMJ, 304, 675–680.
Greer, J. A., Traeger, L., Bemis, H., Solis, J., Hendriksen, E. S., Park, E. R., et al. (2012). A pilot randomized controlled trial of brief cognitive-behavioral therapy for anxiety in patients with terminal cancer. The Oncologist, 17(10), 1337–1345.
Greer, J. A., MacDonal, J., & Traeger, L. (2015). Anxiety disorders. In J. C. Holland, W. S. Breitbart, P. N. Butow, P. B. Jacobsen, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology (3rd ed., pp. 296–303). New York: Oxford University Press.
Harter, M., Reuter, K., Aschenbrenner, A., Schretzmann, B., Marschner, N., Hasenburg, A., & Weis, J. (2001). Psychiatric disorders and associated factors in cancer: Results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. European Journal of Cancer, 37, 1385–1393.
Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., et al. (2014). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 32(18), 1941–1967.
Holland, J. D., Korzun, A. H., Tross, S., Silberfarb, P., Perry, M., Comis, R., & Oster, M. (1986). Comparative psychological disturbance in patients with pancreatic and gastric cancer. The American Journal of Psychiatry, 143, 982–986.
Holland, J. C., Morrow, G. R., Schmale, A., Derogatis, L., Stefanek, M., Berenson, S., et al. (1991). A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. Journal of Clinical Oncology, 9, 1004–1011.
Holland, J. C., Romano, S. J., Heiligenstein, J. H., Tepner, R. G., & Wilson, M. G. (1998). A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-Oncol, 7(4), 291–300.
Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of event scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209–218.
Hotopf, M., Chidgey, J., Addington-Hall, J., & Ly, K. L. (2002). Depression in advanced disease: A systematic review part 1. Prevalence and case finding. Palliative Medicine, 16(2), 81–97.
Howell, D., Keshavarz, H., Esplen, M., Hack, T., Hamel, M., Howes, J., et al. (2015). A Pan Canadian practice guideline: Screening, assessment and care of psychosocial distress, depression, and anxiety in adults with cancer. Toronto: Canadian Partnership Against Cancer and the Canadian Association of Psychosocial Oncology.
Hui, D., Frisbee-Hume, S., Wilson, A., Dibaj, S. S., Nguyen, T., De La Cruz, M., et al. (2017). Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: A randomized clinical trial. JAMA, 318(11), 1047–1056.
Ipser, J. C., & Stein, D. J. (2012). Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). International Journal of Neuropsychopharmacology, 15(6), 825–840.
Jackson, K. C., & Lipman, A. G. (2004). Drug therapy for delirium in terminally ill patients. Cochrane Database of Systematic Reviews, 2, CD004770. https://doi.org/10.1002/14651858.CD004770.
Jacobs, C., Ross, R. D., Walker, I. M., & Stockdale, F. E. (1983). Behavior of cancer patients: A randomized study of the effects of education and peer support groups. American Journal of Clinical Oncology, 6, 347–353.
Jacobsen, P. B., & Butler, R. W. (1996). Relation of cognitive coping and catastrophizing to acute pain and analgesic use following breast cancer surgery. Journal of Behavioral Medicine, 19(1), 17–29.
Jacobsen, P. B., & Donovan, K. A. (2015). Assessment and screening for anxiety and depression. In J. C. Holland, W. S. Breitbart, P. N. Butow, P. B. Jacobsen, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology. New York: Oxford University Press.
Jacobsen, P. B., Donovan, K. A., Swaine, Z. N., & Watson, I. S. (2006). Management of anxiety and depression in adult cancer patients: Toward an evidence-based approach. In A. E. Change, P. A. Ganz, D. F. Hayes, et al. (Eds.), Oncology: An evidence-based approach (pp. 1552–1579). New York: Spriger.
Jacobsson, L. O. (1971). Initial mental disorders in carcinoma of pancreas and stomach. Acta Psychiatric Scand, 220, 120–127.
Jane, S.-W., Wilkie, D. J., Gallucci, B. B., Beaton, R. D., & Huang, H.-Y. (2009). Effects of a full-body massage on pain intensity, anxiety, and physiological relaxation in Taiwanese patients with metastatic bone pain: A pilot study. Journal of Pain and Symptom Management, 37(4), 754–763.
Joffe, R., Rubinow, D., Demicoff, K., Maher, M., & Sindelar, W. F. (1986). Depression and carcinoma of the pancreas. General Hospital Psychiatry, 8, 241–245.
Johannsen, M., Farver, I., Beck, N., & Zachariae, R. (2013). The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: A systematic review and meta-analysis. Breast Cancer Research and Treatment, 138(3), 675–690.
Kane, R. L., Berstein, L., Wales, J., & Rothenberg, R. (1985). Hospice effectiveness in controlling pain. JAMA, 253(18), 2683–2686.
Kangas, M., Henry, J., & Bryant, R. (2005). The course of psychological disorder in the 1st year after cancer diagnosis. Journal of Consulting and Clinical Psychology, 73, 763–768.
Katz, M. R., Irish, J. C., & Devins, G. M. (2004). Development and pilot testing of a psychoeducational intervention for oral cancer patients. Psycho-Oncology, 13(9), 642–653.
Kaynak, H., Kaynak, D., Gözükırmızı, E., & Guilleminault, C. (2004). The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Medicine, 5(1), 15–20.
Kelsen, D. P., Portenoy, R. K., Thaler, H. T., Niedzwiecki, D., Passik, S. D., Tao, Y., et al. (1995). Pain and depression in patients with newly diagnosed pancreas cancer. Journal of Clinical Oncology, 13(3), 748–755.
Krebber, A., Buffart, L., Kleijn, G., Riepma, I., Bree, R., Leemans, C., et al. (2014). Prevalence of depression in cancer patients: A meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology, 23(2), 121–130.
Kroenke, K., Theobald, D., Norton, K., Sanders, R., Schlundt, S., McCalley, S., et al. (2009). The Indiana Cancer Pain and Depression (INCPAD) trial: Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants. General Hospital Psychiatry, 31(3), 240–253. https://doi.org/10.1016/j.genhosppsych.2009.01.007 S0163-8343(09)00014-0 [pii].
Kroenke, K., Theobald, D., Wu, J., Norton, K., Morrison, G., Carpenter, J., & Tu, W. (2010). Effect of telecare management on pain and depression in patients with cancer: A randomized trial. JAMA, 304(2), 163–171. https://doi.org/10.1001/jama.2010.944 304/2/163 [pii].
Krouse, R. S. (2010). Gastrointestinal Cancer. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, M. S. Ledoux, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology. New York: Oxford University Press.
Laird, B. J., Boyd, A. C., Colvin, L. A., & Fallon, M. T. (2009). Are cancer pain and depression interdependent? A systematic review. Psychooncology, 18(5), 459–464. https://doi.org/10.1002/pon.1431.
Leon-Pizarro, C., Gich, I., Barthe, E., Rovirosa, A., Farrus, B., Casas, F., et al. (2007). A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psychooncology, 16(11), 971–979. https://doi.org/10.1002/pon.1171.
Leubbert, K., Dahme, B., & Hasenbring, M. (2001). The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: A meta-analytical reivew. Psycho-Oncol, 10, 490–502.
Levin, T. T., & Alici, Y. (2010). Anxiety disorders. In J. C. Holland, W. S. Breitbart, P. B. Jacobsen, M. S. Ledoux, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology (pp. 324–331). New York: Oxford University Press.
Lie, H., Hjermstad, M., Fayers, P., Finset, A., Kaasa, S., Loge, J., & Collaborative, E. P. C. R. (2015). Depression in advanced cancer–assessment challenges and associations with disease load. Journal of Affective Disorders, 173, 176–184.
Lin, C. C., Lai, Y. L., & Ward, S. E. (2003). Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients. Journal of Pain and Symptom Management, 25(1), 29–37. doi: S0885392402005420 [pii].
Linden, W., & Girgis, A. (2012). Psychological treatment outcomes for cancer patients: What do meta-analyses tell us about distress reduction? Psycho-Oncology, 21(4), 343–350.
Linden, W., Vodermaier, A., MacKenzie, R., & Greig, D. (2012). Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. Journal of Affective Disorders, 141(2), 343–351.
Lovejoy, N. C., & Matteis, M. (1997). Cognitive-behavioral interventions to manage depression in patients with cancer: Research and theoretical initiatives. Cancer Nursing, 20(3), 155–167.
Lovell, M. R., Forder, P. M., Stockler, M. R., Butow, P., Briganti, E. M., Chye, R., et al. (2010). A randomized controlled trial of a standardized educational intervention for patients with cancer pain. Journal of Pain and Symptom Management, 40(1), 49–59. https://doi.org/10.1016/j.jpainsymman.2009.12.013 S0885-3924(10)00309-X [pii].
McQuellon, R. P., Wells, M., Hoffman, S., Craven, B., Russell, G., Cruz, J., et al. (1998). Reducing distress in cancer patients with an orientation program. Psycho-Oncol, 7(3), 207–217.
Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., et al. (2014). Four-week prevalence of mental disorders in patients with cancer across major tumor entities. Journal of Clinical Oncology, 32(31), 3540–3546.
Mehta, R. D., & Roth, A. J. (2015). Psychiatric considerations in the oncology setting. CA: a Cancer Journal for Clinicians, 65(4), 299–314.
Meyer, F., Fletcher, K., Prigerson, H. G., Braun, I. M., & Maciejewski, P. K. (2015). Advanced cancer as a risk for major depressive episodes. Psycho-Oncology, 24(9), 1080–1087.
Miaskowski, C., Dodd, M., & Lee, K. (2004). Symptom clusters: The new frontier in symptom management research. Journal of the National Cancer Institute. Monographs, 32, 17–21.
Miller, K., & Massie, M. J. (2006). Depression and anxiety. Cancer Journal, 12, 388–397.
Miller, K., & Massie, M. J. (2010). Depressive disorders. In J. C. Holland (Ed.), Psycho-oncology (pp. 311–318). New York: Oxford University Press.
Miovic, M., & Block, S. (2007). Psychiatric disorders in advanced cancer. Cancer, 110, 1665–1676. https://doi.org/10.1002/cncr.22980.
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology, 12(2), 160–174.
Montgomery, M., & McCrone, S. H. (2010). Psychological distress associated with the diagnostic phase for suspected breast cancer: Systematic review. Journal of Advanced Nursing, 66(11), 2372–2390.
Moorey, S., Cort, E., Kapari, M., Monroe, B., Hansford, P., Mannix, K., et al. (2009). A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychological Medicine, 39(5), 713–723. https://doi.org/10.1017/S0033291708004169 S0033291708004169 [pii].
Moss, E. L., Simpson, J. S. A., Pelletier, G., & Forsyth, P. (2006). An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psycho-Oncology, 15(3), 259–267.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. The New England Journal of Medicine, 344(13), 961–966. https://doi.org/10.1056/NEJM200103293441303.
Mystakidou, K., Tsilika, E., Parpa, E., Katsouda, E., Galanos, A., & Vlahos, L. (2006). Psychological distress of patients with advanced cancer: Influence and contribution of pain severity and pain interference. Cancer Nursing, 29(5), 400–405. doi: 00002820-200609000-00009 [pii].
National Institute for Clinical Excellence. (2004). Improving supportive and palliative Care for Adults with Cancer. The manual. London: National Institute for Clinical Excellence.
NCCN Clinical practice guidelines in oncology: Distress management. (2017). National Comprehensive Cancer Network.
Newell, S. A., Sanson-Fisher, R. W., & Savolainen, N. J. (2002). Systematic review of psychological therapies for cancer patients: Overview and recommendations for future research. Journal of the National Cancer Institute, 94, 558–584.
Okuyama, T., Akechi, T., Mackenzie, L., & Furukawa, T. A. (2017). Psychotherapy for depression among advanced, incurable cancer patients: A systematic review and meta-analysis. Cancer Treatment Reviews.
Oldenmenger, W. H., Geerling, J. I., Mostovaya, I., Vissers, K. C., de Graeff, A., Reyners, A. K., & van der Linden, Y. M. (2018). A systematic review of the effectiveness of patient-based educational interventions to improve cancer-related pain. Cancer Treatment Reviews, 63, 96–103. https://doi.org/10.1016/j.ctrv.2017.12.005
Orr, K., & Taylor, D. (2007). Psychostimulants in the treatment of depression: A review of the evidence. CNS Drugs, 21(3), 239–257. doi: 2134 [pii].
Orringer, J. S., Fendrick, A. M., Trask, P. C., Bichakjian, C. K., Schwartz, J. L., Wang, T. S., et al. (2005). The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: A randomized, prospective clinical trial. Journal of the American Academy of Dermatology, 53(2), 224–229. https://doi.org/10.1016/j.jaad.2005.03.061 S0190962205010959 [pii].
Osborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006). Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: Meta-analyses. International Journal of Psychiatry in Medicine, 36, 13–34.
Ostuzzi, G., Benda, L., Costa, E., & Barbui, C. (2015a). Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis. Cancer Treatment Reviews, 41(8), 714–724.
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2015b). Antidepressants for the treatment of depression in people with cancer. The Cochrane Library, 1(6), CD011006. https://doi.org/10.1002/14651858.CD011006.pub2.
Padilla, G. V., Ferrell, B., Grant, M. M., & Rhiner, M. (1990). Defining the content domain of quality of life for cancer patients with pain. Cancer Nursing, 13(2), 108–115.
Paice, J. A., & Ferrell, B. (2011). The management of cancer pain. CA: a Cancer Journal for Clinicians, 61(3), 157–182.
Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., Levin, B., et al. (2004). National Institutes of Health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15-17, 2002. Journal of the National Cancer Institute. Monographs, 32, 9–16. https://doi.org/10.1093/jncimonographs/djg014 2004/32/9 [pii].
Pirl, W. F. (2004). Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. Journal of the National Cancer Institute. Monographs, 32, 32–39.
Portenoy, R. K. (2011). Treatment of cancer pain. The Lancet, 377(9784), 2236–2247.
Post-White, J., Kinney, M. E., Savik, K., Gau, J. B., Wilcox, C., & Lerner, I. (2003). Therapeutic massage and healing touch improve symptoms in cancer. Integrative Cancer Therapies, 2(4), 332–344.
Prasertsri, N., Holden, J., Keefe, F. J., & Wilkie, D. J. (2010). Repressive coping style: Relationships with depression, pain, and pain coping strategies in lung cancer out patients. Lung Cancer. https://doi.org/10.1016/j.lungcan.2010.05.009 S0169-5002(10)00224-2 [pii].
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
Raison, C. L., & Miller, A. H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biological Psychiatry, 54(3), 283–294. doi: S000632230300413X [pii].
Ravindran, L. N., & Stein, M. B. (2010). The pharmacologic treatment of anxiety disorders: A review of progress. The Journal of Clinical Psychiatry, 71(7), 839–854. https://doi.org/10.4088/JCP.10r06218blu.
Redd, W. H., Montgomery, G. H., & DuHamel, K. N. (2001). Behavioral intervention for cancer treatment side effects. Journal of the National Cancer Institute, 93, 810–823.
Reilly, C. M., Bruner, D. W., Mitchell, S. A., Minasian, L. M., Basch, E., Dueck, A. C., et al. (2013). A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Supportive Care in Cancer, 21(6), 1525–1550.
Riechelmann, R. P., Burman, D., Tannock, I. F., Rodin, G., & Zimmermann, C. (2010). Phase II trial of mirtazapine for cancer-related cachexia and anorexia. American Journal of Hospice and Palliative Medicine®, 27(2), 106–110.
Rodin, G., Lloyd, N., Katz, M., Green, E., Mackay, J. A., & Wong, R. K. (2007). The treatment of depression in cancer patients: A systematic review. Support Care Cancer, 15(2), 123–136. https://doi.org/10.1007/s00520-006-0145-3.
Roth, A. J., & Massie, M. J. (2007). Anxiety and its management in advanced cancer. Current Opinion in Supportive and Palliative Care, 1, 50–56. https://doi.org/10.1097/SPC.0b013e32813aeb23 01263393-200704000-00012 [pii].
Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J., Goodwin, R. D., Kubzansky, L., et al. (2008). Anxiety disorders and comorbid medical illness. General Hospital Psychiatry, 30, 208–225. https://doi.org/10.1016/j.genhosppsych.2007.12.006 S0163-8343(07)00259-9 [pii].
Savard, J., Simard, S., Giguere, I., Ivers, H., Morin, C. M., Maunsell, E., et al. (2006). Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: Psychological and immunological effects. Palliative & Supportive Care, 4, 219–237.
Schnoll, R. A., Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Glass, M., et al. (2010). A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes & Control, 21(6), 811–820.
Sellick, S. M., & Crooks, D. L. (1999). Depression and cancer: An appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions. Psycho-Oncol, 8, 215–333.
Shakin, E. J., & Holland, J. (1988). Depression and pancreatic cancer. Journal of Pain and Symptom Management, 3(4), 194–198.
Shear, M. K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M. W., et al. (2001). Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depression and Anxiety, 13(4), 166–178.
Sheard, T., & Maguire, P. (1999). The effect of psychological interventions on anxiety and depression in cancer patients: Results of two meta-analyses. British Journal of Cancer, 80, 1770–1780.
Shennan, C., Payne, S., & Fenlon, D. (2011). What is the evidence for the use of mindfulness-based interventions in cancer care? A review. Psycho-Oncology, 20(7), 681–697.
Shi, D. D., Yuppa, D. P., Dutton, T., Brais, L. K., Minden, S. L., Braun, I. M., et al. (2017). Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome. Cancer, 123(14), 2735–2742.
Simon, S. T., Higginson, I. J., Booth, S., Harding, R., & Bausewein, C. (2010). Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database of Systematic Reviews, 1, CD007354. https://doi.org/10.1002/14651858.CD007354.pub2.
Sist, T. C., Florio, G. A., Miner, M. F., Lema, M. J., & Zevon, M. A. (1998). The relationship between depression and pain language in cancer and chronic non-cancer pain patients. Journal of Pain and Symptom Management, 15(6), 350–358. doi: S0885392498000062 [pii].
Smith, A. K., Cenzer, I. S., Knight, S. J., Puntillo, K. A., Widera, E., Williams, B. A., et al. (2010). The epidemiology of pain during the last 2 years of life. Annals of Internal Medicine, 153(9), 563–569.
Smith, P. R., Cope, D., Sherner, T. L., & Walker, D. K. (2014). Update on research-based interventions for anxiety in patients with cancer. Clinical Journal of Oncology Nursing, 18, 5–16.
Speca, M., Carlson, L. E., Goodey, E., & Angen, M. (2000). A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosomatic Medicine, 62(5), 613–622.
Spencer, R., Nilsson, M., Wright, A., Pirl, W., & Prigerson, H. (2010). Anxiety disorders in advanced cancer patients: Correlates and predictors of end-of-life outcomes. Cancer, 116(7), 1810–1819. https://doi.org/10.1002/cncr.24954.
Spiegel, D., & Bloom, J. R. (1983). Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosomatic Medicine, 45, 333–339.
Spiegel, D., Sands, S., & Koopman, C. (1994). Pain and depression in patients with cancer. Cancer, 74(9), 2570–2578.
Spielberger, C. D. (1983). Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press.
Stahl, S. M. (2017). Prescriber’s guide: Stahl’s essential psychopharmacology. Cambridge: Cambridge University Press.
Stark, D. P. H., & House, A. (2000). Anxiety in cancer patients. British Journal of Cancer, 83, 1261–1267.
Stark, D., Kiely, M., Smith, A., Velikova, G., House, A., & Selby, P. (2002). Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life. Journal of Clinical Oncology, 20, 3137–3148.
Steel, J. L., Geller, D. A., Kim, K. H., Butterfield, L. H., Spring, M., Grady, J., et al. (2016). Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting. Cancer, 122(8), 1270–1282.
Stephenson, N. L., Swanson, M., Dalton, J., Keefe, F. J., & Engelke, M. (2007). Partner-delivered reflexology: Effects on cancer pain and anxiety. Oncology Nursing Forum, 34(1), 127–132. https://doi.org/10.1188/07.ONF.127-132 K477114620185X62 [pii].
Strang, P., & Qvarner, H. (1990). Cancer-related pain and its influence on quality of life. Anticancer Research, 10(1), 109–112.
Teunissen, S. C., de Graeff, A., Voest, E. E., & de Haes, J. C. (2007a). Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliative Medicine, 21(4), 341–346. https://doi.org/10.1177/0269216307079067 21/4/341 [pii].
Teunissen, S. C. C. M., Wesker, W., Kruitwagen, C., de Haes, H. C. J. M., Voest, E. E., & de Graeff, A. (2007b). Symptom prevalence in patients with incurable cancer: A systematic review. Journal of Pain and Symptom Management, 34, 94–104.
Thekdi, S. M., Trinidad, A., & Roth, A. (2015). Psychopharmacology in cancer. Current Psychiatry Reports, 17(1), 529.
Theobald, D. E., Kirsh, K. L., Holtsclaw, E., Donaghy, K., & Passik, S. D. (2002). An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. Journal of Pain and Symptom Management, 23(5), 442–447.
Tickoo, R. S., Key, R. G., & Breitbart, W. S. (2015). Cancer-related pain. In J. C. Holland, W. S. Breitbart, P. N. Butow, P. B. Jacobsen, M. J. Loscalzo, & R. McCorkle (Eds.), Psycho-oncology (pp. 171–198). New York: Oxford University Press.
Turk, D. C., Sist, T. C., Okifuji, A., Miner, M. F., Florio, G., Harrison, P., et al. (1998). Adaptation to metastatic cancer pain, regional/local cancer pain and non-cancer pain: Role of psychological and behavioral factors. Pain, 74(2–3), 247–256.
U.S. Food & Drug Administration. (2016). FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Retrieved February 9, 2018, from https://www.fda.gov/Drugs/DrugSafety/ucm518473.htm
U.S. Food & Drug Administration. (2017, December 15). FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses). Retrieved December 21, 2017, from https://www.fda.gov/Drugs/DrugSafety/ucm297391.htm
Uitterhoeve, R. J., Vernooy, M., Litjens, M., Potting, K., Bensing, J., De Mulder, P., & van Achterberg, T. (2004). Psychosocial interventions for patients with advanced cancer – A systematic review of the literature. British Journal of Cancer, 91, 1050–1062. https://doi.org/10.1038/sj.bjc.6602103 6602103 [pii].
Vahdaninia, M., Omidvari, S., & Montazeri, A. (2009). What do predict anxiety and depression in breast cancer patients? A follow-up study. Social Psychiatry and Psychiatric Epidemiology, 45(3), 355–361. https://doi.org/10.1007/s00127-009-0068-7.
Valentine, A. D. (2003). Cancer pain and depression: Management of the dual-diagnosed patient. Current Pain and Headache Reports, 7(4), 262–269.
van den Beuken-van Everdingen, M. H., de Rijke, J. M., Kessels, A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007). Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Annals of Oncology, 18(9), 1437–1449. https://doi.org/10.1093/annonc/mdm056 mdm056 [pii].
van den Beuken-van, M. H., Hochstenbach, L. M., Joosten, E. A., Tjan-Heijnen, V. C., & Janssen, D. J. (2016). Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. Journal of Pain and Symptom Management, 51(6), 1070–1090.e1079.
Vodermaier, A., Linden, W., MacKenzie, R., Greig, D., & Marshall, C. (2011). Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. British Journal of Cancer, 105(12), 1814–1817.
Wang, H.-L., Kroenke, K., Wu, J., Tu, W., Theobald, D., & Rawl, S. M. (2012). Predictors of cancer-related pain improvement over time. Psychosomatic Medicine, 74(6), 642.
Watts, S., Prescott, P., Mason, J., McLeod, N., & Lewith, G. (2015). Depression and anxiety in ovarian cancer: A systematic review and meta-analysis of prevalence rates. BMJ Open, 5(11), e007618.
Wilkinson, S. M., Love, S. B., Westcombe, A. M., Gambles, M. A., Burgess, C. C., Cargill, A., Young, T., Maher, E. J., & Ramirez, A. J. (2007). Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: A multicenter randomized controlled trial. Journal of Clinical Oncology, 25(5), 532–539.
Williams, L. A. (2007). Clinical management of symptom clusters. Sem Onc Nurs, 23, 113–120.
Williams, S., & Dale, J. (2006). The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. British Journal of Cancer, 94, 372–390.
Wilson, K. G., Chochinov, H. M., Skirko, M. G., Allard, P., Chary, S., Gagnon, P. R., et al. (2007). Depression and anxiety disorders in palliative cancer care. Journal of Pain and Symptom Management, 33(2), 118–129. https://doi.org/10.1016/j.jpainsymman.2006.07.016 S0885-3924(06)00588-4 [pii].
Wilson, K. G., Chochinov, H. M., Allard, P., Chary, S., Gagnon, P. R., Macmillan, K., et al. (2009). Prevalence and correlates of pain in the Canadian National Palliative Care Survey. Pain Research & Management, 14(5), 365–370.
Wurzman, R., Jonas, W., & Giordano, J. (2008). Chronic pain and depression: A spectrum disorder? The Pain Practitioner, 18(2), 48–54.
Yates, P., Edwards, H., Nash, R., Aranda, S., Purdie, D., Najman, J., et al. (2004). A randomized controlled trial of a nurse-administered educational intervention for improving cancer pain management in ambulatory settings. Patient Education and Counseling, 53, 227–237.
Yermal, S. J., Witek-Janusek, L., Peterson, J., & Mathews, H. L. (2010). Perioperative pain, psychological distress, and immune function in men undergoing prostatectomy for cancer of the prostate. Biological Research for Nursing, 11(4), 351–362.
Zhang, M.-F., Wen, Y.-S., Liu, W.-Y., Peng, L.-F., Wu, X.-D., & Liu, Q.-W. (2015). Effectiveness of mindfulness-based therapy for reducing anxiety and depression in patients with cancer: A meta-analysis. Medicine, 94(45).
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.
Zimmerman, L., Story, K. T., Gaston-Johansson, F., & Rowles, J. R. (1996). Psychological variables and cancer pain. Cancer Nursing, 19(1), 44–53.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Thompson, L.M., Babilonia, M.B., Rajasekhara, S., Donovan, K.A. (2018). Pain, Depression, and Anxiety in Cancer. In: Moore, R. (eds) Handbook of Pain and Palliative Care. Springer, Cham. https://doi.org/10.1007/978-3-319-95369-4_31
Download citation
DOI: https://doi.org/10.1007/978-3-319-95369-4_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95368-7
Online ISBN: 978-3-319-95369-4
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)